Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Dicerna Pharmaceuticals, Inc. (DRNA)

« Back to company index

DRNA Chatter Timeline

Stock Ticker for DRNA

Most Active Tweeters for DRNA

UserTweets
@AmericanBanking 10
@ThisLincolnian 8
@bibeypost_stock 8
@whatsonthorold2 8
@BlogYomi 7

Recent Tweets for DRNA

OlympiaReport @OlympiaReport
Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Quarterly Sales of $10.59 Million https://t.co/HVS4xqUJ1J
March 21st 2019, 7:03pm
dispatchtribune @dispatchtribune
Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Quarterly Sales of $10.59 Million https://t.co/q3JinVup9T
March 21st 2019, 7:03pm
Stock_News_Now @Stock_News_Now
$DRNA: New SEC Filing for DRNA: Form CT ORDER (No. 9999999997-19-001690): https://t.co/jDd2s35CMp
March 21st 2019, 11:03am
StockTexts @StockTexts
$DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form CT ORDER https://t.co/DdQWCtDDre
March 21st 2019, 10:03am
BlogYomi @BlogYomi
Contrasting of Bellerophon Therapeutics Inc. $DRNA https://t.co/96AGWUx2Ph
March 20th 2019, 7:03pm
brockthornhill @brockthornhill
RT @mikegoodma: $DRNA putting on a little bit of weight every day. Dosing of the first patient with HBV in the 2nd portion of the study sho…
March 20th 2019, 5:03pm
mikegoodma @mikegoodma
$DRNA putting on a little bit of weight every day. Dosing of the first patient with HBV in the 2nd portion of the s… https://t.co/0LAV7yLh4e
March 20th 2019, 5:03pm
thefinreviewer @thefinreviewer
Perigon Wealth Management Has Boosted Its Mcdonalds $MCD Stake; Dicerna Pharmaceuticals, Inc. $DRNA Had 7 Bulls https://t.co/3mHLtzr1qS
March 20th 2019, 1:03pm
mmahotstuff1 @mmahotstuff1
What's Propelling Dicerna Pharmaceuticals, Inc. $DRNA to Increase So Much? https://t.co/LJgOOnCLpi
March 20th 2019, 1:03pm
whatsonthorold2 @whatsonthorold2
Dicerna Pharmaceuticals, Inc. $DRNA's Stock Is Buy After Today's Huge Increase https://t.co/0orb7k06cW
March 20th 2019, 1:03pm
bibeypost_stock @bibeypost_stock
Dicerna Pharmaceuticals, Inc. $DRNA Just Recorded A Sigfniciant Increase https://t.co/dZEx15wItR
March 20th 2019, 1:03pm
OlympiaReport @OlympiaReport
Dicerna Pharmaceuticals Inc $DRNA Given Consensus Rating of “Buy” by Brokerages https://t.co/8sTdJIBKzF
March 20th 2019, 1:03pm
dispatchtribune @dispatchtribune
Dicerna Pharmaceuticals Inc $DRNA Receives $21.78 Average PT from Analysts https://t.co/pHGYm84Hnd
March 20th 2019, 1:03pm
NewsToDesk @NewsToDesk
$DRNA: Will Dicerna Pharmaceuticals, Inc.’s (NASDAQ:DRNA) Earnings …: https://t.co/2o6rFLdEmM
March 20th 2019, 12:03pm
UlmHi @UlmHi
Reviewing PhaseBio Pharmaceuticals Inc. $DRNA's results https://t.co/DAlHtKNsRg
March 20th 2019, 1:03am
UlmHi @UlmHi
Neuralstem Inc. $DRNA Comparing side by side https://t.co/K4wEh2Np81
March 19th 2019, 11:03pm
UlmHi @UlmHi
Immune Design Corp. $DRNA https://t.co/l2aJjw20PI
March 19th 2019, 11:03pm
ConsumerFeed @ConsumerFeed
Dicerna Pharmaceuticals Inc $DRNA Expected to Post Quarterly Sales of $10.59 Million https://t.co/dFwCKw4682
March 19th 2019, 1:03pm
WeekHerald @WeekHerald
Dicerna Pharmaceuticals Inc $DRNA Expected to Post Earnings of -$0.22 Per Share https://t.co/9pe3Vab6L6
March 19th 2019, 1:03pm
OlympiaReport @OlympiaReport
Dicerna Pharmaceuticals Inc $DRNA Expected to Post Earnings of -$0.22 Per Share https://t.co/wEbeJziIlt
March 19th 2019, 1:03pm
bulletin_en @bulletin_en
As Dicerna Pharmaceuticals INC $DRNA Shares Declined, Ra Capital Management LLC Decreased by $14.77 Million Its Sta… https://t.co/oozh37Qi10
March 19th 2019, 7:03am
BlogYomi @BlogYomi
Ghost Tree Capital Has Boosted Dicerna Pharmaceuticals $DRNA Stake by $1.50 Million; Market Value Declined; Zillow… https://t.co/RyKhyZGhg0
March 18th 2019, 4:03pm
stocknewstimes @stocknewstimes
Zacks Investment Research Lowers Dicerna Pharmaceuticals $DRNA to Hold https://t.co/zPkGmc0bXX
March 18th 2019, 10:03am
ChickenhawkBob @ChickenhawkBob
Sold $DRNA + $161 + 6.5% then Bought Back - Profits in the Pocket! https://t.co/AzlOh9VEHi
March 18th 2019, 10:03am
BlogYomi @BlogYomi
SolarWinds $SWI Got Lower Goldman Sachs Rating; Last Week Dicerna Pharmaceuticals, Inc. $DRNA Coverage https://t.co/Jv3TfC8vsS
March 18th 2019, 8:03am
TranscriptDaily @TranscriptDaily
Dicerna Pharmaceuticals Inc $DRNA Given Average Rating of “Buy” by Brokerages https://t.co/ZZ36LWq1f3
March 18th 2019, 7:03am
dakotafinancial @dakotafinancial
Zacks Investment Research Downgrades Dicerna Pharmaceuticals $DRNA to Hold https://t.co/A0cPXKD5Ex
March 17th 2019, 12:03pm
ConsumerFeed @ConsumerFeed
Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Earnings of -$0.22 Per Share https://t.co/tHXHoOHEma
March 17th 2019, 11:03am
WatchlistN @WatchlistN
$10.59 Million in Sales Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/pOVE3JjIZH
March 17th 2019, 11:03am
bibeypost_stock @bibeypost_stock
Ra Capital Management LLC Has Lowered Dicerna Pharmaceuticals INC $DRNA Holding by $14.77 Million https://t.co/iQU7aMWZvL
March 17th 2019, 9:03am
reurope_stock @reurope_stock
Ra Capital Management LLC Has Trimmed Dicerna Pharmaceuticals INC $DRNA Stake by $14.77 Million; Share Value Declin… https://t.co/mTrHoWtCTL
March 17th 2019, 9:03am
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $DRNA? The Short Ratio is 15.75% https://t.co/cK96TdziHl
March 17th 2019, 9:03am
dispatchtribune @dispatchtribune
Dicerna Pharmaceuticals $DRNA Price Target Increased to $26.00 by Analysts at SunTrust Banks https://t.co/s92PlVi27q
March 17th 2019, 8:03am
ThisLincolnian @ThisLincolnian
Dicerna Pharmaceuticals $DRNA Price Target Increased to $26.00 by Analysts at SunTrust Banks https://t.co/CC8qMrdqwS
March 17th 2019, 8:03am
bbnsnews @bbnsnews
Dicerna Pharmaceuticals $DRNA Given New $24.00 Price Target at B. Riley https://t.co/ifqCnGAhBC
March 17th 2019, 5:03am
ThisLincolnian @ThisLincolnian
Q1 2019 Earnings Forecast for Dicerna Pharmaceuticals Inc Issued By Svb Leerink $DRNA https://t.co/Livu79BXhz
March 17th 2019, 1:03am
WeekHerald @WeekHerald
Dicerna Pharmaceuticals Inc $DRNA to Post Q1 2019 Earnings of -$0.43 Per Share, SunTrust Banks Forecasts https://t.co/gGIx8GYxoV
March 17th 2019, 1:03am
OlympiaReport @OlympiaReport
Dicerna Pharmaceuticals Inc $DRNA to Post Q1 2019 Earnings of -$0.43 Per Share, SunTrust Banks Forecasts https://t.co/voujYkwzps
March 17th 2019, 1:03am
BlogYomi @BlogYomi
Reviewing Homology Medicines Inc. $DRNA's results https://t.co/yVZxV21tnH
March 16th 2019, 8:03pm
WeekHerald @WeekHerald
Dicerna Pharmaceuticals $DRNA PT Raised to $26.00 https://t.co/uiPV3Xe4nd
March 16th 2019, 6:03pm
registrarjourn @registrarjourn
Dicerna Pharmaceuticals $DRNA Price Target Raised to $24.00 https://t.co/zJXN8BpOnn
March 16th 2019, 6:03pm
EnterpriseLeade @EnterpriseLeade
Dicerna Pharmaceuticals $DRNA Price Target Raised to $24.00 https://t.co/SnrzvpD8EO
March 16th 2019, 6:03pm
ThisLincolnian @ThisLincolnian
Zacks Investment Research Upgrades Dicerna Pharmaceuticals $DRNA to “Buy” https://t.co/S5fDSCy1h0
March 16th 2019, 6:03pm
OlympiaReport @OlympiaReport
SunTrust Banks Boosts Dicerna Pharmaceuticals $DRNA Price Target to $26.00 https://t.co/TJaMTtLWsH
March 16th 2019, 6:03pm
TickerReport @TickerReport
Dicerna Pharmaceuticals Inc $DRNA Receives $21.78 Average PT from Brokerages https://t.co/SPruhzMuAC
March 16th 2019, 6:03pm
bibeypost_stock @bibeypost_stock
It's been a crucial week for Dicerna Pharmaceuticals, Inc. $DRNA; here's what analysts have to say. https://t.co/ATNvcfXMF6
March 16th 2019, 8:03am
TranscriptDaily @TranscriptDaily
Dicerna Pharmaceuticals $DRNA Stock Rating Lowered by Zacks Investment Research https://t.co/b6x832ha69
March 16th 2019, 4:03am
registrarjourn @registrarjourn
Dicerna Pharmaceuticals $DRNA Downgraded to “Hold” at BidaskClub https://t.co/aSZnzIpSgL
March 16th 2019, 3:03am
EnterpriseLeade @EnterpriseLeade
Dicerna Pharmaceuticals $DRNA Downgraded to “Hold” at BidaskClub https://t.co/Yxc5AZGz26
March 16th 2019, 3:03am
registrarjourn @registrarjourn
Dicerna Pharmaceuticals Inc $DRNA to Post Q1 2019 Earnings of -$0.43 Per Share, SunTrust Banks Forecasts https://t.co/nQAk8JwpYV
March 16th 2019, 2:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.